Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols-Reference-Cited by-同舟云学术

Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols

Published:2018-11-14 Issue:2 Volume:145 Page:445-455
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Abendroth A.,Noureddine R.,Abramczyk M.,Paul A.,Gerken G.,Schmid K. W.,Markus P.,Schumacher B.,Wiesweg M.,Köhler J.,Markus M.,Mende B.,Dechêne A.,Schuler M.,Kasper S.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s00432-018-2789-z/fulltext.html

Reference26 articles.

1. Bosman FT, Carneiro F (2010) WHO Classification of Tumours of the Digestive System (World Health Organization Classification of Tumours, Volume 3) WHO Classification of Tumours

2. Brodowicz T, Wolfram RM, Kostler WJ et al (2000) Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer. Anticancer Drugs 11:623–628

3. Burris HA, Moore III, Andersen MJ J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413

4. Conroy T, Desseigne F, Ychou M et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817–1825

5. Dragovich T, Huberman M, Von Hoff DD et al (2007) Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial. Cancer Chemother Pharmacol 60:295–303

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia;Cancer Letters;2024-04

2. Predicting overall survival and resection in patients with locally advanced pancreatic cancer treated with FOLFIRINOX: Development and internal validation of two nomograms;Journal of Surgical Oncology;2021-06-11

3. Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy;Journal of Cancer Research and Clinical Oncology;2020-08-25

4. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine;Biomedicine & Pharmacotherapy;2020-05

5. Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy;JCI Insight;2020-04-23